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The Impact of Epidural Steroid Injections on
the Outcomes of Patients Treated for
Lumbar Disc Herniation
A Subgroup Analysis of the SPORT Trial
Kristen Radcliff, MD, Alan Hilibrand, MD, Jon D. Lurie, MD, Tor D. Tosteson, ScD, Lawrence Delasotta, MD, Jeffrey Rihn, MD,
Wenyan Zhao, PhD, Alexander Vaccaro, MD, PhD, Todd J. Albert, MD, and James N. Weinstein, MD
Investigation performed at the Department of Orthopedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania,
and the Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
Background: The Spine Patient Outcomes Research Trial (SPORT) is a prospective, multicenter study of operative versus
nonoperative treatment of lumbar intervertebral disc herniation. It has been suggested that epidural steroid injectionsmay
help improve patient outcomes and lower the rate of crossover to surgical treatment.
Methods: One hundred and fifty-four patients included in the intervertebral disc herniation arm of the SPORT who had
received an epidural steroid injection during the first three months of the study and no injection prior to the study (the ESI
group) were compared with 453 patients who had not received an injection during the first three months of the study or
prior to the study (the No-ESI group).
Results: There was a significant difference in the preference for surgery between groups (19% in the ESI group compared
with 56% in the No-ESI group, p < 0.001). There was no difference in primary or secondary outcomemeasures at four years
between the groups. A higher percentage of patients changed from surgical to nonsurgical treatment in the ESI group (41%
versus 12% in the No-ESI, p < 0.001).
Conclusions: Patients with lumbar disc herniation treated with epidural steroid injection had no improvement in short or long-
term outcomes compared with patients who were not treated with epidural steroid injection. There was a higher prevalence of
crossover to nonsurgical treatment among surgically assigned ESI-group patients, although this was confounded by the
increased baseline desire to avoid surgery among patients in the ESI group. Given these data, we concluded that more studies
are necessary to establish the value of epidural steroid injection for symptomatic lumbar intervertebral disc herniation.
Level of Evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
L
umbar disc herniation is the most common cause of
lumbar radiculopathy1. Nonoperative management of this
conditionmay include physical therapy, anti-inflammatory
medications, and epidural steroid injections2-5. Epidural ste-
roid injection may modulate the inflammatory cells, cyto-
kines, or other pain mediators associated with lumbar disc
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herniation-related pain6-9, although it is not believed that an
epidural steroid injection directly causes regression of a herni-
ated nucleus pulposus10.
There is considerable controversy about the clinical
efficacy of epidural steroid injections in the management of
lumbar disc herniation. Improvements in outcome have been
reported at three5, six11, sixteen12, and eighteen13 months after
epidural steroid injections. Other studies have demonstrated
no difference in outcome after epidural steroid injection1,12,14-18.
The largest study of epidural injections is a prospective, ran-
domized trial of 160 patients, and this study showed a benefit of
steroid treatment at two weeks but none at three, six, or twelve
months15.
To our knowledge, the study with the longest follow-up
after epidural steroid injections was reported by Riew et al.19.
The study included fifty-five nonsurgically treated patients who
received an epidural steroid injection or a placebo injection in a
mixed cohort of patients with both intervertebral disc herni-
ation and spinal stenosis. The authors’ main finding was that
patients who received an epidural steroid injection were sig-
nificantly more likely to cross over from surgical to nonoperative
treatment. However, the authors reported no difference in North
American Spine Society20 outcome scores between the epidural
steroid and placebo-injection groups after a minimum of one
year21 or five years19 of follow-up to account for this ‘‘surgical
avoidance.’’
In the previous literature regarding epidural steroid in-
jection, the experimental variable was injection of a specific
agent compared with a placebo10,13,18,22-24. We are aware of only
one other study that compared an epidural steroid injectionwith
non-injection, nonsurgical treatment of lumbar disc herniation
without an injection. Buchner et al. randomized thirty-eight
patients with a lumbar disc herniation to either receive or not
receive an epidural steroid injection22. The authors found a
nonsignificant trend toward improvement in the epidural ste-
roid injection group. Despite this uncertainty about thera-
peutic benefit, the utilization of epidural steroid injections has
increased significantly in the United States25. Previous studies
have also demonstrated an association between epidural steroid
injection and an increased rate of surgery25,26.
The purpose of this study was to determine how the
administration of epidural steroid injections affects the out-
come of patients with lumbar radiculopathy from lumbar disc
herniation in the SPORT study. In particular, our goal was to
measure the effect of epidural steroid injections on primary
outcome measures of pain and function and disease-specific
measures. We hypothesized that patients receiving epidural
steroid injections during treatment would have improved out-
comes and would be more likely to cross over from operative
to nonoperative treatment when compared with patients not
receiving an epidural steroid injection.
Materials and Methods
Study Design
The Spine Patient Outcomes Research Trial (SPORT) was conducted atthirteen multidisciplinary spine practices in eleven states across the United
States. The details of the methods have been reported previously
4,5,27,28
. The
prospective data collection in SPORT provides a method to evaluate the effect
of epidural steroid injection on the outcome of treatment of patients with
lumbar radiculopathy. In the observational cohort of the lumbar intervertebral
disc herniation study, 50% (360) of the patients received preenrollment epi-
dural steroid injection and 38% (274) received epidural steroid injection during
treatment. In the randomized cohort, 42% (199) received preenrollment epi-
dural steroid injection and 50% (236) received epidural steroid injection during
treatment
29
.
Patients
The human subject committees at each center approved the standardized pro-
tocol. Inclusion criteria for the study were an age of over eighteen years, radicular
pain for six weeks, and a positive nerve root tension sign and/or neurological
deficit. The diagnosis of radiculopathy was confirmed by cross-sectional images
(magnetic resonance imaging [MRI], or a computed tomography [CT] my-
elogram if the patient was unable to undergo MRI) that demonstrated in-
tervertebral disc herniation at the level that corresponded to the symptoms.
Exclusion criteria included cauda equina syndrome, progressive neurological
deficit, malignant tumor, scoliosis of >15, disc herniation cephalad to L2,
prior back surgery, and other established contraindications to elective surgery.
Patients were offered participation in either a randomized or an observational
cohort.
Study Interventions
The patients in the surgery group were designated to receive lumbar discectomy.
The nonoperative protocol was ‘‘usual recommended care,’’ which included, at
least, active physical therapy, education and counseling with instructions re-
garding home exercise, and nonsteroidal anti-inflammatory drugs if the patient
could tolerate them. Nonoperative treatment options also included epidural
steroid injections.
Study Measures
Data used in this study were obtained prospectively, and reviewed retrospec-
tively, from patient questionnaires completed at baseline as well as six weeks, three
months, six months, one year, two years, three years, and four years following sur-
gery. Primary outcome measures included the bodily pain (BP), physical function
(PF), and the physical and mental component summary (PCS and MCS) do-
mains of the Short Form-36 (SF-36)
30
as well as the American Academy of
Orthopaedic Surgeons version of the Oswestry Disability Index (ODI)
20
. Sec-
ondary measures included patient self-reported improvement, work status, and
satisfaction with current symptoms
31
. Symptom severity was measured by the
low back pain bothersomeness (LBP) scale and the sciatica bothersomeness
(SBI) and leg pain bothersomeness (LPI) indices
32,33
. The SF-36 and the ODI
range from 0 to 100; the SBI, from 0 to 24; and the LBP scale, from 0 to 6.
Higher scores indicate more severe symptoms on the ODI, SBI, and LBP scale,
whereas higher scores indicate less severe symptoms on the SF-36.
Comparison
The change in primary outcome measures in patients who received epidural
steroid injection (the ESI group) was compared with that in a group of patients
who did not receive epidural steroid injection (the No-ESI group) as part of
their treatment for intervertebral disc herniation within SPORT. To fairly assess
the effect of epidural steroid injection, we excluded patients who underwent
such an injection prior to their enrollment in SPORT (Fig. 1). We also included
only patients who had received an epidural injection during the first three
months of enrollment in the SPORT. The three-month time point was selected
to exclude patients who received epidural steroid injection later in the course of
the SPORT as a ‘‘salvage’’ intervention after a failed initial attempt at nonsur-
gical treatment. The majority (77%) of patients in the ESI group received the
injection within the first three months of enrollment.
Patients who received epidural steroid injection with any technique (in-
cluding interlaminar, transforaminal, and caudal) during the first three months
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of enrollment were included in the ESI group. The prospective data collected in
this study did not include injection type or whether fluoroscopic guidance had
been used.
Statistical Analysis
Baseline characteristics were compared between the groups by using a chi-
square test for categorical variables and a t test for continuous variables.
Outcomes were analyzed by using longitudinal mixed-effect models with
random individual effect to account for repeated individual observations over
time. Covariate adjustment predictedmissing data, treatment received, baseline
differences, and outcomes included in the model. In addition, outcome, center,
age, and sex were included in all longitudinal outcome models. All analyses
were as-treated, and treatment was considered to be a time-varying covariate.
Therefore, patients categorized at each time point either had received or had
not received surgical treatment. Follow-up times were measured from the
beginning of treatment, and baseline covariates were updated at the time of
surgery. All observations prior to surgery were considered in the nonoperative
estimate with follow-up time measured from enrollment. All observations
following surgery contributed to the surgical estimate with follow-up time
measured from the time of surgery. Secondary and binary outcomes were
analyzed by using generalized estimation equations that assumed a compound
symmetry working correlation structure. Outcome comparisons between the
ESI and No-ESI groups were made at each time point with multiple degrees of
freedom by using Wald tests. Across the four-year follow-up interval, overall
comparisons of the area under the curve were made by using a Wald test.
Significance was defined as p < 0.05 on the basis of a two-sided hypothesis with
no adjustment made for multiple comparisons.
A post hoc power analysis
34
was performed by using a two-sample t test.
On the basis of the standard deviations and sample sizes from our data, there
was 80% power to detect an effect size of 0.1 in the SF-36 BP and PF domains
and a 0.46-point difference in the ODI between the surgically treated patient
groups. The study had an 80% power to detect a 0.7-point difference in the
SF-36 BP and PF domains and a 0.5-point difference in the ODI between the
nonsurgically treated patient groups.
Because of extensive crossover in the randomized cohort and similar
baseline characteristics and outcomes between the patients in the randomized
and observational groups when they were analyzed according to treatment, the
two groups were combined in this ‘‘as-treated’’ analysis. Patients were con-
sidered ‘‘surgically assigned’’ if they had been randomized to receive surgery or
had chosen surgical treatment in the observational cohort. A change from the
assigned treatment (in the case of the randomized cohort) or the chosen
treatment (in the case of the observational cohort) was defined as ‘‘crossover.’’
During the course of the SPORT, patients who initially elected to have, or were
assigned to receive, nonsurgical treatment may have changed their minds and
ultimately undergone surgical intervention. Conversely, patients who initially
elected to undergo surgical intervention or were randomized to have surgery
may have changed their minds in the interval between enrollment in the
SPORT and their surgery date and thus crossed over to the nonsurgical treat-
ment arm.
Source of Funding
Funding was received from the National Institute of Arthritis and Muscu-
loskeletal and Skin Diseases (U01-AR45444) and the Office of Research on
Women’s Health, the National Institutes of Health, and the National Institute
of Occupational Safety and Health, the Centers for Disease Control and
Prevention.
Results
Demographics
The eligible patient population included 625 patients whodid not receive epidural steroid injections prior to enroll-
ment in SPORT (Fig. 1). Six hundred and seven patients had
complete information about utilization of epidural steroid in-
jections at the six-week or three-month follow-up interval, and
eighteen were excluded because of incomplete information. Of
these 607 patients, 154 received an epidural steroid injection
during the first three months of treatment (the ESI group) and
453 did not receive an epidural steroid injection (the No-ESI
group). Seventy-seven percent of the patients who received an
epidural steroid injection did so within the first three months.
The baseline characteristics and demographics of the ESI
and No-ESI cohorts are presented in the Appendix. There were
baseline differences between groups with regard to the per-
centages of patients of white race (ESI: 79% versus No-ESI:
87%, p = 0.041), with full or part-time work status (ESI: 65%
versus No-ESI: 60%, p = 0.031), with depression (ESI: 16%
versus No-ESI: 9%, p = 0.034), with other comorbidity (ESI:
53% versus No-ESI: 43%, p = 0.039), whose treatment pref-
erence at baseline was surgery (ESI: 19% versus No-ESI: 56%,
p < 0.001), with any neurological deficit (ESI: 70% versus No-
ESI: 79%, p = 0.027), with an asymmetric sensory decrease
(ESI: 43% versus No-ESI: 53%, p = 0.03), and who received
Fig. 1
Study design of this subgroup analysis. Comparison of change in outcomemeasures between the patients treated with epidural steroid injection (ESI) and
those not treated with epidural steroid injection (No ESI) in the surgical and nonsurgical groups was performed in an ‘‘as-treated’’ analysis.
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surgery (ESI: 48% versus No-ESI: 69%, p < 0.001). The groups
also differed with regard to the mean baseline SF-36 MCS
scores, favoring the No-ESI group (ESI: 43.9 versus No-ESI:
46.5, p = 0.012).
Operative details are presented in the Appendix. There
was no significant difference in the details of the surgery, in-
cluding operative time, blood loss, dural tear rate, or compli-
cations of surgery, between the ESI and No-ESI groups. There
was also no difference in the rate of revision surgery at one to
four years.
The adjusted change in the outcome measures over four
years in the ESI group compared with the No-ESI group is
illustrated in Figure 2 and the Appendix. The change in
outcome measures was adjusted for age, sex, marital status,
smoking status, race, compensation (Workers’ Compensa-
tion, Social Security compensation, or other compensation),
herniation level and type, work status, depression, self-rated
health trend, treatment preference at baseline, baseline SF-36
score, ODI, SBI, and symptom duration. There were no sig-
nificant differences in primary or secondary outcome mea-
sures between the surgically treated ESI and No-ESI groups or
between the nonsurgically treated ESI and No-ESI groups at
the four year time point or in the area-under-the-curve av-
erage measurements. There were no significant differences in
the primary outcome measures between the ESI and Non-ESI
groups at one, two, or three years regardless of whether they
were treated surgically or nonsurgically. Outcome measures
were further measured at each individual time point (see
Appendix); there was significantly less satisfaction in the sur-
gically treated ESI group (64.5%) than in the surgically treated
non-ESI group (80.6%) at one year (p = 0.02). There was a
corresponding increase in the treatment effect of surgery on
patient satisfaction in the No-ESI group (ESI: 15.8 versus No-
ESI: 40, p = 0.012). At one year, there was also an increase in the
percentage of working patients in the nonsurgically treated ESI
group (ESI: 89.9% versus No-ESI: 78.2%, p = 0.049). The
treatment effect of surgery on work status was increased at one
year in the No-ESI group (10.7). The treatment effect on work
status was decreased in the ESI group (211.6, p = 0.005).
There were no significant differences at two or three years
between the ESI and No-ESI groups. There were also no sig-
nificant differences in the treatment effect of surgery between
the ESI and No-ESI groups at four years or averaged over the
study period.
Change from the assigned or chosen treatment (defined
as ‘‘crossover’’) by the patients in the surgical and nonsurgical
groups is reported in the Appendix. The percentage of patients
assigned to receive surgical treatment who crossed over to
undergo nonsurgical treatment was significantly increased in
the ESI group (ESI: 41% versus No-ESI: 12%, p < 0.001). There
was also a trend toward an increased percentage of patients
assigned to nonoperative treatment crossing over to undergo
surgical treatment in the ESI group (ESI: 42% versus No-ESI:
30%, p = 0.057). The crossover was further subdivided ac-
cording to baseline preference for surgery. Analysis of the pa-
tients who had a baseline preference for surgery (see Appendix)
showed a significant increase in crossover to nonsurgical treat-
ment in the ESI group (13%) compared with the non-ESI group
(1%, p = 0.044). There was no significant difference in cross-
over from nonsurgical to surgical treatment between the ESI
group (60%) and the No-ESI group (79%) (p = 0.276) who had
a baseline preference for surgery. Analysis of the patients who
had a baseline preference for nonsurgical treatment (see Ap-
pendix) showed no significant difference in crossover from
Fig. 2
Change in primary outcome measures between patients with an intradiscal disc herniation (IDH) who received epidural steroid injection (ESI) or did not
receive epidural steroid injection (No-ESI) within the first three months after enrollment.
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surgery to nonsurgical treatment between the ESI (48%) and
No-ESI (56%) groups (p = 0.623). Conversely, there was no
significant difference in crossover from nonsurgical to surgical
treatment between the ESI (33%) and No-ESI (20%) groups
who had a baseline preference for nonsurgical treatment (p =
0.084).
Discussion
These results indicate no significant difference in outcomeat one, two, three, or four years between patients who
received an epidural steroid injection and those who did not
receive an epidural injection for the treatment of lumbar disc
herniation in the SPORT study. However, an increased rate
of surgical avoidance was noted in the group treated with an
epidural steroid injection.
These results are similar to those of Buchner et al.22, who
also found no difference in the outcomes of injection and no-
injection treatment. At the one year follow-up evaluation in our
study, there was less satisfaction among the surgically treated
patients who had had an epidural steroid injection, suggesting
that patients who ultimately had surgery were less satisfied as
a result of having had the additional procedure. However, the
early outcome differences were not significant over the course
of the remainder of the study period.
Similar to previous studies13,21, our results suggest that
epidural steroid injections are associated with surgical avoid-
ance (a 41% rate of crossover by surgically assigned patients
who received epidural steroid injection compared with a 12%
rate of crossover by surgically assigned patients who did not
receive an epidural steroid injection), although this is heavily
influenced by the baseline preference for surgery. Epidural
steroid injection was not associated with surgical avoidance
or increased crossover to surgery by patients with a baseline
preference for nonsurgical treatment. Among patients who
had a baseline preference for surgery, epidural steroid injec-
tion was associated with a higher rate of crossover from sur-
gical to nonsurgical treatment. One plausible explanation for
the differences is possible selection bias—i.e., patients who
received an epidural steroid injection may have been less ideal
surgical candidates. This assessment of baseline preference
has not been reported in other studies on ‘‘surgical avoid-
ance,’’ including that of Riew et al.19. Furthermore, surgical
avoidance may not be an ideal goal in the absence of a long-
term improvement in outcome with nonsurgical treatment or
even equivalence in outcome between surgical and nonsurgi-
cal treatment. Our results suggest that patients who ‘‘avoided
surgery’’ may have had less improvement than they would
have otherwise had.
This study had several unique strengths compared with
the previous studies. Patient enrollment in our study (n = 607)
far exceeded that of the next largest published study (n =
160)27. This reduced the possibility of type-II error con-
founding our results. Since this was a retrospective analysis of
prospectively collected data, an a priori power analysis was
not performed. We performed a post hoc power analysis to
determine the effect size that we were powered to detect in the
SF-36 and ODI outcome instruments34. Based on the numbers
available, there was adequate power to detect the mean dif-
ferences between groups in the four-year area-under-curve
results with the exception of the SF-36 BP domain among
the nonsurgically treated patients. The study had an 80%
power to detect a difference of 0.7 in the SF-36 BP domain
among the nonsurgically treated patients. However, the ob-
served effect size was 0.6. Furthermore, the post hoc analysis
showed adequate statistical power to detect a minimum clini-
cally important difference in primary outcome measures. The
strict SPORT inclusion criteria limit our results to patients with
intervertebral disc herniation only, as opposed to those with
either intervertebral disc herniation or spinal stenosis19,21.
Furthermore, the duration of follow-up (four years) in this
study is significantly longer than that in many previous stud-
ies1-3,9,10,13,14,17,18,22,23,29. The current study also includes outcome
assessments of surgically treated patients with and without
epidural steroid injection, which enables an estimation of the
treatment effect of surgery and crossover in both directions. We
did not find any significant increase in the incidence of dural
tear, spinal fluid leak, postoperative infection, or neurological
injury when comparing surgical patients who had had a pre-
operative epidural steroid injection with those who had not.
Therefore, we do not believe that there is a substantial disad-
vantage of epidural steroid injection in patients who ultimately
undergo surgical intervention.
Weaknesses of this study include the possibility of an
unknown baseline confounder or selection bias between the
ESI and No-ESI groups that would limit the generalizability of
the results. Although the known confounders of lumbar disc
herniation treatment outcomes (obesity, duration of symp-
toms, and compensation status) did not differ significantly
among the patient cohorts, there is the possibility that an un-
known confounder influenced the results. At baseline, there
were differences between the ESI and No-ESI groups in SF-36
MCS score and prevalence of depression, suggesting worse
overall baseline mental health in the ESI group. There were
also clinical differences, including a decreased prevalence of
physical findings including neurological deficits and asym-
metric sensory decreases in the ESI group. Despite these
baseline differences in demographic parameters and clinical
factors, there were no significant differences in the primary
outcome measures: SF-36 PCS or ODI.
We conclude that further study is necessary to determine
the long-term value of epidural steroid injections, given the
substantial growing national volume of use and cost of epidural
steroid injection.
Appendix
Tables showing baseline demographics, comorbidities,
clinical findings, and health status measures; operative
treatments, complications, and events; change scores and treat-
ment effects for primary and secondary outcomes according
to treatment received; average area-under-the-curve results
over four years; crossover of assigned/chosen treatment groups;
percentage of patients who underwent surgery at each time
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point; and crossover of assigned/chosen treatment groups for
patients who had baseline preference for surgery and those with
a baseline preference for nonoperative treatment are available
with the online version of this article as a data supplement at
jbjs.org. n
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